Topical antiviral formulations
AssigneeViravert LLC
InventorsDarby C. Brown, Kristen A. Brown
Life of this patent
Estimating the term…
Abstract
The disclosure provides novel topical antiviral pharmaceutical compositions comprising one or more antiviral compounds and 2-deoxy-D-glucose in the form of lip-balms, creams and ointments. A specific embodiment discloses a lip-balm composition comprising acyclovir and 2-deoxy-D-glucose.
Claims34
A topical pharmaceutical composition comprising
- a therapeutically effective amount of an antiviral compound selected from one or more of the group consisting of acyclovir, vidarabine, azidothymidine, ganciclovir, famciclovir, penciclovir, brivudine, cidofovir, trifluridine, and foscarnet;
- and a pharmaceutically acceptable salt or hydrate thereof;
- and
- a therapeutically effective amount of 2-deoxy-D-glucose.
(canceled)
A method of treating a herpes viral infection of the skin or mucosa of a patient in need thereof comprising topically administering to the skin or mucosa a pharmaceutical composition comprising
- a therapeutically effective amount of an antiviral compound selected from acyclovir, vidarabine, azidothymidine, ganciclovir, famciclovir, penciclovir, brivudine, cidofovir, trifluridine, or foscarnet, or a pharmaceutically acceptable salt thereof, and
- a therapeutically effective amount of 2-deoxy-D-glucose.
(canceled)
A method of reducing the duration of a herpes viral infection outbreak of the skin or mucosa of a mammal in need thereof comprising administering to the skin or mucosa a pharmaceutical composition comprising
- a therapeutically effective amount of an antiviral compound selected from acyclovir, vidarabine, azidothymidine, ganciclovir, famciclovir, penciclovir, brivudine, cidofovir, trifluridine, or foscarnet, or a pharmaceutically acceptable salt thereof, and
- a therapeutically effective amount of 2-deoxy-D-glucose.
(canceled)
Dependencies are inferred from the claim text.